Milan, Italy

Salvatore Forenza


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Salvatore Forenza: Innovator in Anti-Tumor Compounds

Introduction

Salvatore Forenza is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor compounds. His work has the potential to impact cancer treatment and improve patient outcomes.

Latest Patents

Forenza holds a patent for "Anthracycline glycosides, their preparation, use and compositions thereof." This patent describes compounds that exhibit anti-tumor activity. The compounds are characterized by a specific formula, where R₁ can be hydrogen, hydroxy, or methoxy, R₂ can be hydrogen or hydroxy, and R₃ and R₄ can independently be hydrogen or methyl, with the condition that R₃ and R₄ are not both hydrogen. The patent also covers the processes for producing and using these compounds, as well as therapeutic compositions that contain them. He has 1 patent to his name.

Career Highlights

Forenza is associated with Farmitalia Carlo Erba S.p.a., a company known for its focus on pharmaceutical innovations. His work at the company has allowed him to explore and develop new therapeutic options for cancer treatment.

Collaborations

Throughout his career, Forenza has collaborated with esteemed colleagues such as Giuseppe Cassinelli and Maria C Ripamonti. These collaborations have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Salvatore Forenza's contributions to the field of anti-tumor compounds highlight his innovative spirit and dedication to improving cancer therapies. His patent and work at Farmitalia Carlo Erba S.p.a. reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…